Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F9CSQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,905
Award facts
- Contract value 100% obligated
- $19,904.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,904.54 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2ml pen format on January 6, 2026, with completion scheduled for January 7, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Cosentyx is a biologic immunosuppressant used primarily to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. This delivery order reflects DLA's continued reliance on AmerisourceBergen's extensive pharmaceutical distribution network to procure specialty medications required by military treatment facilities and veterans' healthcare programs. AmerisourceBergen's position as a critical federal vendor is evidenced by its significant contract portfolio across multiple therapeutic domains and its established capability to fulfill both routine and specialized medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F9CSQ?
SPE2DR26F9CSQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F9CSQ worth?
The government has obligated $19,905 on SPE2DR26F9CSQ.
Is contract SPE2DR26F9CSQ an order under another contract?
Yes. SPE2DR26F9CSQ is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9CSQ competed?
The extent of competition for SPE2DR26F9CSQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award